placeholder image
G. J. Gerstner All authors
About
Publications While At HealthPartners
Highlights
selected publications
Journal Article
  • Phase II study of docetaxel and trametinib in patients with KRAS mutation positive recurrent non-small cell lung cancer (NSCLC; SWOG S1507, NCT-02642042). 
    Clinical Cancer Research. 2023
  • Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial. 
    Lancet Oncology. 2016
    • Contact
    full name
  • G. J. Gerstner
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at HealthPartners. Publications in prior years appear in grey.
    Collaboration